Explore the role of platform trials in accelerating clinical research for scleroderma in this informative 31-minute video presentation. Gain insights into the basics of platform trials before delving into CONQUEST, an innovative platform clinical trial designed to rapidly advance promising treatments and identify agents for progression from phase 2b to phase 3 trials. Learn from experts Gregory Gordon, MD, JD, Dinesh Khanna, MD, MS, and Tobey Maher, MD, as they discuss the potential impact of this approach on scleroderma research. Originally presented at the 3rd annual SRF Patient Forum, "Collaborating for a Cure," this session offers valuable knowledge for patients, researchers, and healthcare professionals interested in advancing scleroderma treatment options.